Analyst firms · UBS · ALGT
UBS ALGT price target and rating history
Allegiant Travel Company (ALGT) · Consumer Discretionary
UBS rates Allegiant Travel Company (ALGT) Buy with a $107 price target, as of its latest action on Sep 14, 2026. It has published 3 rating actions on ALGT since November 2024, including 1 upgrade and 0 downgrades. Across 9 firms with a ALGT price target in the last 12 months, the median target is $116. UBS's $107 is 8% below that.
- Current rating
- Buy
- Price target
- $107
- Median target, all firms
- $116
- Actions on ALGT
- 3
UBS price target on ALGT
Every UBS rating on ALGT
- Sep 14, 2026
- Jul 7, 2025
- Nov 26, 2024
How other firms rate ALGT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $107 | Sep 14, 2026 |
| Raymond James | Strong Buy | $116 | Aug 24, 2026 |
| Barclays | Overweight | $145 | Jul 8, 2026 |
| Melius | Buy | $160 | Jul 7, 2026 |
| Citigroup | Buy | $156 | Jun 26, 2026 |
| Goldman Sachs | Buy | $125 | Jun 17, 2026 |
| Wolfe Research | Outperform | $108 | Jan 20, 2026 |
| BofA Securities | Neutral | $95 | Jan 6, 2026 |
| Deutsche Bank | Buy | $105 | Dec 12, 2025 |
Questions about UBS and ALGT
- What is UBS's price target for ALGT?
- UBS's latest stated price target for Allegiant Travel Company (ALGT) is $107, from its action on Sep 14, 2026.
- What is UBS's rating on ALGT?
- UBS rates ALGT Buy, a bullish rating, as of Sep 14, 2026.
- When did UBS last change its view on ALGT?
- On Sep 14, 2026, UBS upgrades to Buy from Neutral, price target $107.
- How does UBS's ALGT target compare with other analysts?
- Across 9 firms with a ALGT price target in the last 12 months, the median target is $116. UBS's $107 is 8% below that.
More ALGT rating histories
- Raymond James6
- Barclays3
- Goldman Sachs5
- Wolfe Research4
- BofA Securities3
- Deutsche Bank5
- TD Cowen9
- Morgan Stanley4
All UBS ratingsALGT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.